Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02437890
Brief Title: A Phase II Study to Evaluate Safety and Efficacy of ALX-0061 in Subjects With Systemic Lupus Erythematosus

First Submitted : April 29, 2015
First Submitted that Met QC Criteria : May 7, 2015
First Posted : May 8, 2015 (Estimate)

Results First Submitted : November 16, 2018
Results First Submitted that Met QC Criteria : January 17, 2019
Results First Posted : February 6, 2019

Certification/Extension First Submitted : November 5, 2018
Certification/Extension First Submitted that Met QC Criteria : November 5, 2018
Certification/Extension First Posted : November 6, 2018

Last Update Submitted that Met QC Criteria : February 12, 2019
Last Update Posted : February 26, 2019